The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.
FDA’s Drug Industry Fees Fuel Concerns Over Influence
Clinical Trials Drugs (Pharmaceuticals) Food and Drug Administration Generic Brands and Products Infant Formulas Law and Legislation Lobbying and Lobbyists Medical Devices Medicine and Health Pharmaceutical Research and Manufacturers of America Prices (Fares, Fees and Rates) Regulation and Deregulation of Industry United States Politics and Government
Leave a Reply